541299 DLCL

Dr. Lalchandani Labs Share Price

₹18.73 +1.58 (9.21%)

21 Nov, 2024 21:26

SIP TrendupStart SIP in DLCL

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -3.2%
  • Over 3 Month -14.08%
  • Over 6 Month -14.47%
  • Over 1 Year -46.49%
SIP Lightning

Smart Investing Starts Here Start SIP with Dr. Lalchandani Labs for Steady Growth!

Invest Now

Dr. Lalchandani Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Dr. Lalchandani Labs Financials

Dr. Lalchandani Labs Technicals

EMA & SMA

Current Price
₹18.73
+ 1.58 (9.21%)
pointer
  • stock-down_img
  • Bullish Moving Average 5
  • stock-up_img
  • Bearish Moving Average 11
  • 20 Day
  • ₹18.77
  • 50 Day
  • ₹20.02
  • 100 Day
  • ₹21.22
  • 200 Day
  • ₹22.98

Resistance and Support

18.98 Pivot Speed
  • R3 19.98
  • R2 19.73
  • R1 19.23
  • S1 18.48
  • S2 18.23
  • S3 17.73

What's your outlook on Dr. Lalchandani Labs?

You can only vote for once

Dr. Lalchandani Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-14 Half Yearly Results
2024-05-30 Audited Results
2023-11-14 Half Yearly Results
2023-06-16 Audited Results (Revised)
2022-11-14 Half Yearly Results

Dr. Lalchandani Labs F&O

Dr. Lalchandani Labs Shareholding Pattern

No data available.

About Dr. Lalchandani Labs

  • NSE Symbol
  • DLCL
  • BSE Symbol
  • 541299
  • ISIN
  • INE871Z01013

Similar Stocks to Dr. Lalchandani Labs

Dr. Lalchandani Labs FAQs

Dr. Lalchandani Labs share price is ₹18 As on 21 November, 2024 | 21:12

The Market Cap of Dr. Lalchandani Labs is ₹8.1 Cr As on 21 November, 2024 | 21:12

The P/E ratio of Dr. Lalchandani Labs is As on 21 November, 2024 | 21:12

The PB ratio of Dr. Lalchandani Labs is 0.9 As on 21 November, 2024 | 21:12

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23